Fortis Healthcare slips as its arm receives SEBI notice in funds diversion case
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Fortis Healthcare is currently trading at Rs. 204.10, down by 2.05 points or 0.99% from its previous closing of Rs. 206.15 on the BSE.
The scrip opened at Rs. 206.90 and has touched a high and low of Rs. 206.90 and Rs. 202.50 respectively. So far 72968 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 227.20 on 05-Apr-2021 and a 52 week low of Rs. 113.20 on 26-May-2020.
Last one week high and low of the scrip stood at Rs. 215.95 and Rs. 199.05 respectively. The current market cap of the company is Rs. 15408.70 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 47.99% and 20.84% respectively.
Fortis Healthcare’s subsidiary -- Escorts Heart Institute and Research Center (EHIRCL) has received a notice from capital markets regulator SEBI in the matter related to the alleged diversion of funds from the company by its erstwhile promoters. EHIRCL received the notice on April 15, 2021.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning various countries.
is currently trading at Rs. 204.10, down by 2.05 points or 0.99% from its previous closing of Rs. 206.15 on the BSE.
The scrip opened at Rs. 206.90 and has touched a high and low of Rs. 206.90 and Rs. 202.50 respectively. So far 72968 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 227.20 on 05-Apr-2021 and a 52 week low of Rs. 113.20 on 26-May-2020.
Last one week high and low of the scrip stood at Rs. 215.95 and Rs. 199.05 respectively. The current market cap of the company is Rs. 15408.70 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 47.99% and 20.84% respectively.
Fortis Healthcare’s subsidiary -- Escorts Heart Institute and Research Center (EHIRCL) has received a notice from capital markets regulator SEBI in the matter related to the alleged diversion of funds from the company by its erstwhile promoters. EHIRCL received the notice on April 15, 2021.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning various countries.
Fortis Healthcare is currently trading at Rs. 204.10, down by 2.05 points or 0.99% from its previous closing of Rs. 206.15 on the BSE.
The scrip opened at Rs. 206.90 and has touched a high and low of Rs. 206.90 and Rs. 202.50 respectively. So far 72968 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 227.20 on 05-Apr-2021 and a 52 week low of Rs. 113.20 on 26-May-2020.
Last one week high and low of the scrip stood at Rs. 215.95 and Rs. 199.05 respectively. The current market cap of the company is Rs. 15408.70 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 47.99% and 20.84% respectively.
Fortis Healthcare’s subsidiary -- Escorts Heart Institute and Research Center (EHIRCL) has received a notice from capital markets regulator SEBI in the matter related to the alleged diversion of funds from the company by its erstwhile promoters. EHIRCL received the notice on April 15, 2021.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning various countries.
Fortis Healthcare is currently trading at Rs. 204.10, down by 2.05 points or 0.99% from its previous closing of Rs. 206.15 on the BSE.
The scrip opened at Rs. 206.90 and has touched a high and low of Rs. 206.90 and Rs. 202.50 respectively. So far 72968 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 227.20 on 05-Apr-2021 and a 52 week low of Rs. 113.20 on 26-May-2020.
Last one week high and low of the scrip stood at Rs. 215.95 and Rs. 199.05 respectively. The current market cap of the company is Rs. 15408.70 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 47.99% and 20.84% respectively.
Fortis Healthcare’s subsidiary -- Escorts Heart Institute and Research Center (EHIRCL) has received a notice from capital markets regulator SEBI in the matter related to the alleged diversion of funds from the company by its erstwhile promoters. EHIRCL received the notice on April 15, 2021.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning various countries.
Fortis Healthcare is currently trading at Rs. 204.10, down by 2.05 points or 0.99% from its previous closing of Rs. 206.15 on the BSE.
The scrip opened at Rs. 206.90 and has touched a high and low of Rs. 206.90 and Rs. 202.50 respectively. So far 72968 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 227.20 on 05-Apr-2021 and a 52 week low of Rs. 113.20 on 26-May-2020.
Last one week high and low of the scrip stood at Rs. 215.95 and Rs. 199.05 respectively. The current market cap of the company is Rs. 15408.70 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 47.99% and 20.84% respectively.
Fortis Healthcare’s subsidiary -- Escorts Heart Institute and Research Center (EHIRCL) has received a notice from capital markets regulator SEBI in the matter related to the alleged diversion of funds from the company by its erstwhile promoters. EHIRCL received the notice on April 15, 2021.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning various countries.
